Merck, known as MSD outside the United States and Canada, today announced the appointment of Roger M. Perlmutter, M.D., Ph.D., as executive vice president and president of Merck Research Laboratories ...
Read more
January 24, 2013 8:05 am by Staley, Eddie | 0 Comments
Pfizer (NYSE: PFE) announced today that a Phase 4 study assessing the efficacy and safety of Toviaz (fesoterodine fumarate) 8 mg once daily in patients with overactive bladder (OAB) compared ...
Read more
October 23, 2012 1:35 pm by Staley, Eddie | 0 Comments
C. R. Bard (NYSE: BCR) today announced that it has entered into a definitive agreement to acquire privately-held Neomend, Inc., a leading developer and supplier of sprayable surgical sealants and ...
Read more
October 23, 2012 9:13 am by Staley, Eddie | 0 Comments
AstraZeneca and Ironwood Pharmaceuticals (NASDAQ: IRWD) announced today an agreement to co-develop and co-commercialize Ironwood's linaclotide in China. Linaclotide is the first and only guanylate cyclase-C (GC-C) agonist approved by ...
Read more
October 19, 2012 3:15 pm by Staley, Eddie | 0 Comments
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced today that it has received approval from the United States Food and ...
Read more
October 18, 2012 2:34 pm by Staley, Eddie | 0 Comments
Aetna (NYSE: AET) today announced that it will launch a new Mobile Field Enrollment tool for iPad for its in-field Medicare sales agents and brokers. Licensed Aetna agents and brokers ...
Read more
October 17, 2012 8:21 am by Staley, Eddie | 0 Comments
The Food and Drug Administration Commissioner Margaret Hamburg has told scientific advisers that the FDA is considering a faster pathway for obesity treatments, life-saving antibiotics and other drugs deemed to ...
Read more
October 16, 2012 9:31 am by Staley, Eddie | 0 Comments
SHPS ("SHPS") an independent provider of health and wellness services, has sold its collaborative care management software subsidiary Landacorp, Inc. to a wholly-owned subsidiary of ExlService Holdings, Inc. (EXL). EXL ...
Read more
October 11, 2012 9:48 am by Staley, Eddie | 0 Comments
Rosetta Genomics (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that E. Robert Wassman, M.D. and Dganit Bar, Ph.D. will join the Company in the ...
Read more
October 3, 2012 9:41 am by Staley, Eddie | 0 Comments
Today, Booz Allen Hamilton announced that it has won 35 healthcare contracts, totaling more than $112 million, in August and September 2012 to support a wide range of federal healthcare ...
Read more
September 25, 2012 4:31 pm by Staley, Eddie | 0 Comments
Depomed (Nasdaq: DEPO) today announced that it has filed an action in federal district court for the District of Columbia against the Food and Drug Administration, seeking an order requiring ...
Read more
September 21, 2012 4:02 pm by Staley, Eddie | 0 Comments
Watson Laboratories, Inc. today issued a voluntary nationwide recall for two lots of Hydrocodone Bitartrate and APAP Tablets, USP 10 mg/500 mg. A customer complaint was received for tablets that ...
Read more
September 21, 2012 2:08 pm by Staley, Eddie | 0 Comments
Regeneron Pharmaceuticals (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA (aflibercept) Injection for the treatment of Macular Edema following Central Retinal Vein Occlusion ...
Read more
September 4, 2012 11:01 am by Staley, Eddie | 0 Comments
Roche (OTC: RHHBY) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its IgG Antibody to herpes simplex virus (HSV) types 1 and ...
Read more
